Ligand validation:7PGA

VAK: methyl (1R,2R,4S)-2-ethyl-2,4,5,7-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate

VAK is a Ligand Of Interest in 7PGA designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7PGA_VAK_A_402	12%	7%	0.314	0.849	2.54	2.2	9	5	11	0	100%	0.86
7PGA_VAK_B_402	11%	11%	0.312	0.833	2.4	1.77	8	7	1	0	100%	0.85
7PGA_VAK_C_402	11%	8%	0.336	0.852	2.53	2.2	9	5	4	0	100%	0.86
7PGA_VAK_D_402	7%	11%	0.36	0.81	2.39	1.76	8	7	8	0	100%	0.85
7PHE_VAK_B_401	54%	15%	0.169	0.933	2.53	1.24	8	4	0	0	100%	0.98
7PHF_VAK_D_402	1%	12%	0.459	0.663	2.46	1.61	7	5	18	0	100%	0.83
3IHG_VAK_B_537	62%	15%	0.15	0.941	2.24	1.53	9	9	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.